Anavex Life Sciences Corp...
11.24
0.77 (7.35%)
At close: Jan 15, 2025, 1:40 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Cash & Equivalents 132.19M 151.02M 149.16M 152.11M 29.25M 22.19M 22.93M 27.44M 9.19M 15.29M 7.26M 345.07K 11.36K 134.70K 264.67K 350.99K 6.36K 25.00 12.28K 977.00 28.11K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a 16.36K n/a n/a 52.40K 52.40K 52.40K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables 2.45M 2.71M 3.19M 9.14M 4.85M 2.64M 1.87M 9.75K 79.35K 76.84K n/a n/a n/a 809.00 37.82K n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a 16.36K n/a -2.64M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 931.00K 653.00K 354.00K 371.91K 443.84K 501.00K 1.25M 335.93K 180.12K 100.84K 89.12K 48.38K 1.22K 65.09K 23.27K 55.96K n/a n/a 220.00 n/a n/a
Total Current Assets 135.57M 154.39M 152.70M 161.62M 34.54M 25.33M 24.32M 27.79M 9.45M 15.47M 7.35M 393.45K 12.58K 200.60K 325.76K 406.95K 6.36K 25.00 12.49K 977.00 28.11K
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.25K 2.25K n/a 576.00 2.43K 4.09K 1.69K 862.00 n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets n/a n/a n/a 16.36K n/a n/a 52.40K 52.40K 52.40K 1.25K 2.25K n/a 576.00 2.43K 4.09K 1.69K 862.00 n/a n/a n/a n/a
Total Assets 135.57M 154.39M 152.70M 161.62M 34.54M 25.33M 24.38M 27.84M 9.50M 15.47M 7.35M 393.45K 13.15K 203.04K 329.85K 408.64K 7.22K 25.00 12.49K 977.00 28.11K
Account Payables 9.63M 4.32M 3.82M 4.74M 3.99M 3.52M 2.96M 3.58M 3.06M 2.47M 1.22M 1.71M 2.46K 410.02K 797.76K 1.59M 749.39K 462.53K 8.01K 17.06K n/a
Deferred Revenue 842.00K n/a 443.83K 443.83K n/a n/a n/a n/a 70.53K 71.61K -1.22M -1.71M -2.46K n/a n/a -4.10M -2.30M n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a 85.24K 192.06K 210.86K 299.00K 867.92K 2.49M 2.51M 1.55M n/a 20.00K n/a n/a
Other Current Liabilities 4.83M 8.21M 6.39M 5.61M 3.32M 1.52M 929.33K n/a 14.84M 104.61K 28.23K 30.45K 2.59M 67.50K n/a n/a n/a n/a n/a 9.94K 2.50K
Total Current Liabilities 15.30M 12.53M 10.21M 10.80M 7.31M 5.04M 3.88M 3.58M 3.19M 2.66M 1.44M 1.95M 2.89M 1.35M 3.29M 4.10M 2.30M 462.53K 28.01K 27.00K 2.50K
Long-Term Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a 332.00 5.72M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities 4.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 4.83M n/a 4.27M 5.61M 3.32M 1.52M n/a n/a n/a 332.00 5.72M 904.00K n/a n/a n/a 168.00K n/a n/a n/a n/a n/a
Total Liabilities 15.30M 12.53M 10.21M 10.80M 7.31M 5.04M 3.88M 3.58M 3.19M 2.66M 7.16M 2.86M 2.89M 1.35M 3.29M 4.27M 2.30M 462.53K 28.01K 27.00K 2.50K
Total Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a 85.57K 5.91M 210.86K 299.00K 867.92K 2.49M 2.51M 1.55M n/a 20.00K n/a n/a
Common Stock 85.00K 82.00K 77.94K 75.92K 62.05K 52.65K 45.94K 43.33K 36.17K 32.04K 47.20K 37.24K 30.24K 26.57K 23.52K 20.75K 19.96K 19.52K 19.20K 3.20K 2.00K
Retained Earnings -336.07M -293.07M -245.56M -197.59M -159.68M -133.40M -108.93M -91.48M -78.02M -63.28M -52.57M -41.20M -37.50M -29.20M -21.90M -12.56M -7.06M -1.71M -131.55K -106.02K -14.39K
Comprehensive Income n/a 0.00 0.00 -0.00 n/a n/a n/a n/a n/a -1.76K -768 -5.63K -5.05K -3.20K -1.54K -630 125.85K n/a n/a n/a n/a
Shareholders Equity 120.26M 141.85M 142.49M 150.82M 27.24M 20.29M 20.49M 24.25M 6.31M 12.81M 192.63K -2.46M -2.88M -1.14M -2.96M -3.86M -2.29M -462.50K -15.51K -26.02K 25.61K
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a